Aequs Limited Board Approves Equity Infusion

Rs 650 Cr Infusion through Warrants by Promoter Group; 50 per cent Payable Upfront Of the total issue size of approximately ₹650 crore, ₹325 crore will be payable upfront upon allotment of the warrants, representing 50 per cent of the issue size, and twice the regulatory minimum. The balance will be payable upon exercise of the warrants. In accordance with applicable regulations, warrant may be exercised within 18 months from the date of allotment. However, conversion of warrants into equity shares, by making payment of balance consideration, shall take place on or before December 31, 2027. Promoter has undertaken to pay the balance consideration in full, irrespective of the market price of the Company’s shares at the time of exercise. The Company has received an investment commitment letter dated September 25, 2026, from Promoter to this effect. The issue price of Rs 231.55 is the floor price determined under Regulation 164 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 — the higher of the 90-trading-day and the 10-trading-day volume weighted average price of the Company’s shares preceding the relevant date of September 22, 2026. On full conversion of the warrants, the aggregate Oholding of the Promoter and Promoter Group in the Company will increase from 59.09 per cent to 60.73 per cent. Opinion : This News will have postive impact on the stock price in short to long term Disclaimer : This is not a buy sell or hold recommendation. I do not hold this stock